# Spring-loaded Core Biopsy Device Market to Reach USD 256 Million by 2034
According to a new report by **Intel Market Research**, the global **Spring-loaded Core Biopsy Device market** was valued at **USD 186 million in 2025** and is projected to reach **USD 256 million by 2034**, registering a **CAGR of 4.8%** during the forecast period (2025–2034).
Spring-loaded Core Biopsy Devices are minimally invasive medical instruments designed to obtain high-quality tissue samples for diagnostic analysis. Equipped with a spring-activated biopsy needle and an ergonomic handle, these devices enable rapid and precise tissue collection while minimizing patient discomfort. They are widely used for breast, liver, kidney, prostate, lymph node, and other tissue biopsies, supporting accurate histopathological diagnosis and personalized treatment planning.
Full Report: https://www.intelmarketresearc....h.com/spring-loaded-
